ES8403929A1 - "procedimiento para la preparacion de 6,16-dimetilcorticoides" - Google Patents

"procedimiento para la preparacion de 6,16-dimetilcorticoides"

Info

Publication number
ES8403929A1
ES8403929A1 ES524238A ES524238A ES8403929A1 ES 8403929 A1 ES8403929 A1 ES 8403929A1 ES 524238 A ES524238 A ES 524238A ES 524238 A ES524238 A ES 524238A ES 8403929 A1 ES8403929 A1 ES 8403929A1
Authority
ES
Spain
Prior art keywords
preparation
formyl
chlorine
carbon atoms
bond
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES524238A
Other languages
English (en)
Other versions
ES524238A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of ES8403929A1 publication Critical patent/ES8403929A1/es
Publication of ES524238A0 publication Critical patent/ES524238A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/0085—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes
    • C07J71/0015—Oxiranes at position 9(11)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Manufacture Of Tobacco Products (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Detergent Compositions (AREA)

Abstract

PROCEDIMIENTO PARA LA PREPARACION DE 6,16-DIMETILCORTICOIDES, DE FORMULA GENERAL (I), EN LA QUE EL ENLACE INDICADO EN LA FORMULA REPRESENTA UN ENLACE SIMPLE O UN ENLACE DOBLE; X SIGNIFICA UN ATOMO DE HIDROGENO, UN ATOMO DE FLUOR, UN ATOMO DE CLORO O UN ATOMO DE BROMO; R1 SIGNIFICA UN GRUPO FORMILO O UN GRUPO ALCANOILO; E Y SIGNIFICA UN ATOMO DE CLORO, UN GRUPO HIDROXI O UN GRUPO ALCANOILOXI.CONSISTE EN ABRIR CON FLUORURO DE HIDROGENO EL ANILLO EPOXIDO DE UN ESTEROIDE DE FORMULA GENERAL (II), EN LA QUE EL ENLACE, R1 E Y TIENEN LOS SIGNIFICADOS YA MENCIONADOS.DEAPLICACION EN LA TERAPIA DE ENFERMEDADES ALERGICAS DE LAS VIAS RESPIRATORIAS Y DEL TRACTO INTESTINAL.
ES524238A 1982-07-19 1983-07-19 "procedimiento para la preparacion de 6,16-dimetilcorticoides" Granted ES524238A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3227312A DE3227312A1 (de) 1982-07-19 1982-07-19 Neue 6,16-dimethylkortikoide, ihre herstellung und verwendung

Publications (2)

Publication Number Publication Date
ES8403929A1 true ES8403929A1 (es) 1984-04-16
ES524238A0 ES524238A0 (es) 1984-04-16

Family

ID=6168986

Family Applications (1)

Application Number Title Priority Date Filing Date
ES524238A Granted ES524238A0 (es) 1982-07-19 1983-07-19 "procedimiento para la preparacion de 6,16-dimetilcorticoides"

Country Status (23)

Country Link
US (2) US4555507A (es)
EP (1) EP0100874B1 (es)
JP (1) JPS5967298A (es)
AT (1) ATE50780T1 (es)
AU (1) AU1694183A (es)
BG (2) BG43692A3 (es)
CA (1) CA1312856C (es)
DD (1) DD214134A5 (es)
DE (2) DE3227312A1 (es)
DK (1) DK162232C (es)
ES (1) ES524238A0 (es)
FI (1) FI832575A (es)
GB (1) GB2124230A (es)
GR (1) GR78902B (es)
HU (1) HU191539B (es)
IE (1) IE55771B1 (es)
IL (1) IL69230A (es)
NO (1) NO157453C (es)
PH (1) PH19976A (es)
PL (1) PL141537B1 (es)
PT (1) PT76995B (es)
RO (4) RO92854A (es)
ZA (1) ZA835249B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3227312A1 (de) * 1982-07-19 1984-01-19 Schering AG, 1000 Berlin und 4709 Bergkamen Neue 6,16-dimethylkortikoide, ihre herstellung und verwendung
DE3400188A1 (de) * 1984-01-02 1985-07-11 Schering AG, Berlin und Bergkamen, 1000 Berlin Neue 6(alpha),16(alpha)-dimethylkortikoide
DE3401680A1 (de) * 1984-01-16 1985-07-18 Schering AG, 1000 Berlin und 4709 Bergkamen 6(alpha),16ss-dimethylkortikoide
PT78973A (en) * 1984-07-25 1984-08-01 Joao Emerico Villax New preparation process of the 9alpha-fluoro 17,21-acylates or hidroxilades in 17 and 21 chloro-corticosteroid
US5319115A (en) * 1987-08-25 1994-06-07 Cocensys Inc. Method for making 3α-hydroxy, 3β-substituted-pregnanes
US4866050A (en) * 1988-04-27 1989-09-12 Ben Amoz Daniel Ultrasonic transdermal application of steroid compositions
DE3915951C1 (es) * 1989-05-12 1990-09-13 Schering Ag, 1000 Berlin Und 4709 Bergkamen, De
WO1991014700A2 (en) * 1990-03-27 1991-10-03 Schering Corporation PROCESS FOR 9α-HYDROXY STEROID DEHYDRATION
FR2701262B1 (fr) * 1993-02-05 1995-03-24 Roussel Uclaf Nouveau procédé de préparation de stéroïdes 6 alpa, 9 alpha-difluorés et nouveaus intermédiaires.
DE4333920A1 (de) * 1993-10-05 1995-04-13 Hoechst Ag Corticoid-17,21-dicarbonsäureester sowie Corticosteroid-17-carbonsäureester-21-kohlensäureester, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
US5502222A (en) * 1994-06-01 1996-03-26 Schering Corporation Process for preparing delta 9,11 and 21-chloro corticosteroids
KR101701404B1 (ko) * 2008-05-28 2017-02-01 레베라겐 바이오파마 인코포레이티드 질환의 치료를 위한 ＮＦ-κＢ 의 비호르몬성 스테로이드 조절제
WO2011127048A2 (en) 2010-04-05 2011-10-13 Validus Biopharma NON-HORMONAL STEROID MODULATORS OF NF-ĸB FOR TREATMENT OF DISEASE
US10799514B2 (en) 2015-06-29 2020-10-13 Reveragen Biopharma, Inc. Non-hormonal steroid modulators of NF-kappa beta for treatment of disease
US11382922B2 (en) 2019-03-07 2022-07-12 Reveragen Biopharma, Inc. Aqueous oral pharmaceutical suspension compositions

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU75903A1 (es) * 1976-09-29 1978-05-16
GB931221A (en) * 1958-10-01 1963-07-17 Merck & Co Inc Steroid compounds
GB898291A (en) * 1959-03-18 1962-06-06 Upjohn Co Improvements in or relating to steroids and the manufacture thereof
GB898292A (en) * 1959-03-18 1962-06-06 Upjohn Co Improvements in or relating to steroids and the manufacture thereof
DE1195748B (de) * 1961-06-24 1965-07-01 Vismara Francesco Spa Verfahren zur Herstellung von 1'-substituierten 17alpha, 21-(1'-Alkoxy)-methylendioxysterioden
US3054811A (en) * 1961-09-14 1962-09-18 Merck & Co Inc Ring a unsaturated 6, 16-dimethyl steroids of the pregnane series
GB1047518A (en) * 1963-06-11 1966-11-02 Glaxo Lab Ltd 17ª‡-monoesters of 11,17,21-trihydroxy steroid compounds
GB1047519A (en) * 1963-06-11 1966-11-02 Glaxo Lab Ltd 17ª‡,21-diesters of 11,17,21-trihydroxy steroid compounds
GB1544642A (en) * 1976-06-04 1979-04-25 Bristol Myers Co 9,11-epoxy steroids and synthesis of corticosteroids therefrom
DE2645105C2 (de) * 1976-10-04 1986-03-13 Schering AG, 1000 Berlin und 4709 Bergkamen Derivate des 9-Chlorprednisolons, Verfahren zu ihrer Herstellung und diese enthaltendes pharmazeutisches Präparat
DE2715854A1 (de) * 1977-04-06 1978-10-19 Schering Ag Verfahren zur herstellung von 11alpha,21-dihydroxy-1,4-pregnadien- 3,20-dion-derivaten
US4086254A (en) * 1977-04-13 1978-04-25 The Upjohn Company Photocleavable steroids
DE2759135A1 (de) * 1977-12-30 1979-07-19 Lark Spa Neue steroidverbindungen und deren herstellung und verwendung
US4154748A (en) * 1978-01-20 1979-05-15 The Upjohn Company Phosphate catalyzed acylation of steroidal tertiary alcohols
DE2803661A1 (de) * 1978-01-25 1979-07-26 Schering Ag Neue in 17-position substituierte 11beta-hydroxysteroide der pregnanreihe, ihre herstellung und verwendung
DE2901561A1 (de) * 1979-01-12 1980-07-31 Schering Ag Verfahren zur herstellung von 11 beta, 17 alpha, 21-trihydroxy-4-pregnen-3,20dion-derivaten
EP0054786B1 (de) * 1980-12-23 1985-03-20 Schering Aktiengesellschaft Neue 6-alpha-Methylhydrocortison-Derivate, ihre Herstellung und Verwendung
DE3227312A1 (de) * 1982-07-19 1984-01-19 Schering AG, 1000 Berlin und 4709 Bergkamen Neue 6,16-dimethylkortikoide, ihre herstellung und verwendung

Also Published As

Publication number Publication date
FI832575A (fi) 1984-01-20
DE3381291D1 (de) 1990-04-12
DD214134A5 (de) 1984-10-03
GB2124230A (en) 1984-02-15
IE55771B1 (en) 1991-01-16
PT76995A (de) 1983-08-01
IL69230A (en) 1988-07-31
RO92853B1 (ro) 1987-12-01
US4555507A (en) 1985-11-26
RO92853A2 (ro) 1987-11-30
CA1312856C (en) 1993-01-19
PT76995B (de) 1986-01-09
GR78902B (es) 1984-10-02
IE831658L (en) 1984-01-19
NO157453C (no) 1988-03-23
GB8319363D0 (en) 1983-08-17
DK162232C (da) 1992-03-02
EP0100874A3 (en) 1985-04-17
ZA835249B (en) 1984-03-28
EP0100874A2 (de) 1984-02-22
DK162232B (da) 1991-09-30
NO157453B (no) 1987-12-14
JPH0415239B2 (es) 1992-03-17
BG43693A3 (en) 1988-07-15
BG43692A3 (en) 1988-07-15
US4701451A (en) 1987-10-20
PL243082A1 (en) 1984-11-19
ATE50780T1 (de) 1990-03-15
RO92854A (ro) 1987-11-30
PL141537B1 (en) 1987-08-31
HU191539B (en) 1987-03-30
FI832575A0 (fi) 1983-07-14
RO92856A (ro) 1987-11-30
ES524238A0 (es) 1984-04-16
DE3227312A1 (de) 1984-01-19
JPS5967298A (ja) 1984-04-16
NO832609L (no) 1984-01-20
IL69230A0 (en) 1983-11-30
EP0100874B1 (de) 1990-03-07
DK329183A (da) 1984-01-20
PH19976A (en) 1986-08-26
AU1694183A (en) 1984-01-26
DK329183D0 (da) 1983-07-18
RO92855A (ro) 1987-11-30

Similar Documents

Publication Publication Date Title
ES8403929A1 (es) "procedimiento para la preparacion de 6,16-dimetilcorticoides"
ES2012197A6 (es) Procedimiento para preparar derivados 17beta-oh-19-nor-esteroides sustituidos en 17alfa.
ES461875A1 (es) Procedimiento de preparacion de nuevos derivados del piperi-dil-indol.
ES8100273A1 (es) Procedimiento para la preparacion de nuevos derivados de alfa-(3,4-diclorofenil)-2-imidazolina-2-metanol y alfa-(3,4-diclorofenil)-1,4,5,6-tetrahidro-2-pirimidinametanol
ES8405421A1 (es) Procedimiento para la preparacion de nuevos 6 -metilcorticoides
EP0149222A3 (en) 6-alpha, 16 alpha-dimethyl corticoids
EP0149464A3 (en) 6-alpha, 16-beta-dimethyl steroids
GR79666B (es)
ES8307896A1 (es) "procedimiento para la preparacion de derivados de 6a-metilhdrocortisona".
AU1918583A (en) Antiviral 5-halovinyl-2'-deoxyuridines
ES461688A1 (es) Un procedimiento para la preparacion de nuevos compuestos decefalosporina.
ES8601931A1 (es) Procedimiento para preparar imidazoles y triazoles con es- tructura de enoleter

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20020506